Diazepam 5mg/ml Solution for Injection Malta - English - Medicines Authority

diazepam 5mg/ml solution for injection

wockhardt uk limited ash road north, wrexham, ll13 9uf, united kingdom - diazepam - solution for injection - diazepam 5 mg/ml - psycholeptics

Diazedin 5 mg/ml inj. sol. i.v. amp. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

diazedin 5 mg/ml inj. sol. i.v. amp.

vetviva richter gmbh - diazepam 5 mg/ml - solution for injection - 5 mg/ml - diazepam 5 mg/ml - diazepam - dog; cat

Solupam 5 mg/ml inj. sol. i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

solupam 5 mg/ml inj. sol. i.v. vial

dechra regulatory b.v. - diazepam 5 mg/ml - solution for injection - 5 mg/ml - diazepam 5 mg/ml - diazepam - dog; cat

Ziapam 5 mg/ml inj. sol. i.v. amp. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ziapam 5 mg/ml inj. sol. i.v. amp.

domes pharma - diazepam 5 mg/ml - solution for injection - 5 mg/ml - diazepam 5 mg/ml - diazepam - dog; cat

DIAZEPAM 5 Mg/Ml Solution for Injection Ireland - English - HPRA (Health Products Regulatory Authority)

diazepam 5 mg/ml solution for injection

wockhardt uk limited - diazepam - solution for injection - 5 mg/ml - benzodiazepine derivatives

DIAZEPAM 5 Mg/Ml Solution for Injection Ireland - English - HPRA (Health Products Regulatory Authority)

diazepam 5 mg/ml solution for injection

wockhardt uk limited - diazepam - solution for injection - 5 mg/ml - benzodiazepine derivatives

Diazepam (AstraZeneca) New Zealand - English - Medsafe (Medicines Safety Authority)

diazepam (astrazeneca)

astrazeneca limited - diazepam 5 mg/ml - solution for injection - 5 mg/ml - active: diazepam 5 mg/ml excipient: benzoic acid benzyl alcohol ethanol propylene glycol sodium benzoate sodium hydroxide water for injection

Diazepam (AstraZeneca) New Zealand - English - Medsafe (Medicines Safety Authority)

diazepam (astrazeneca)

astrazeneca limited - diazepam 5 mg/ml - solution for injection - 5 mg/ml - active: diazepam 5 mg/ml excipient: benzoic acid benzyl alcohol ethanol propylene glycol sodium benzoate sodium hydroxide water for injection

DBL™ Diazepam Injection New Zealand - English - Medsafe (Medicines Safety Authority)

dbl™ diazepam injection

pfizer new zealand limited - diazepam 5 mg/ml; diazepam 5 mg/ml - solution for injection - 10 mg/2ml - active: diazepam 5 mg/ml excipient: benzoic acid benzyl alcohol ethanol propylene glycol sodium benzoate water for injection active: diazepam 5 mg/ml excipient: ethanol propylene glycol sodium hydroxide water for injection - tension and anxiety states; status epilepticus; as preoperative medication; skeletal muscle spasm and motor unrest; cerebral palsy; athetosis; stiff-man syndrome; tetanus and acute agitation due to alcohol withdrawal.

Dobutamine-hameln 12.5 mg/ml concentrate for solution for infusion New Zealand - English - Medsafe (Medicines Safety Authority)

dobutamine-hameln 12.5 mg/ml concentrate for solution for infusion

max health limited - dobutamine hydrochloride 14 mg/ml equivalent to dobutamine 12.5 mg/ml, 250 mg dobutamine in 20 ml;   - concentrate for infusion - 12.5 mg/ml - active: dobutamine hydrochloride 14 mg/ml equivalent to dobutamine 12.5 mg/ml, 250 mg dobutamine in 20 ml   excipient: hydrochloric acid sodium metabisulfite water for injection - dobutamine hydrochloride is indicated when inotropic support is necessary for the treatment of patients with hypoperfusion states in whom cardiac output is insufficient to meet circulatory demands. dobutamine hydrochloride is also indicated when inotropic support is required for the treatment of patients in whom abnormally increased ventricular filling pressures introduce the risk of pulmonary congestion and oedema. conditions which may precipitate such situations include the following hypoperfusion states: initially cardiac in origin: a. acute heart failure acute myocardial infarction, cardiogenic shock, following cardiac surgery, medicine-induced depression of cardiac contractility such as that which occurs in excessive ?-adrenergic receptor blockade. b. chronic heart failure acute decompensation of chronic congestive heart failure, temporary inotropic support in advanced chronic congestive heart failure, as an adjunct to therapy with conventional oral inotropic agents, systemic vasodilators, and diuretics. initially noncardiac in origin: acute hypoperfusion states secondary to trauma, surgery, sepsis, or hypovolaemia when mean arterial pressure is above 70-mm hg and pulmonary capillary wedge pressure is 18-mm hg or greater, with inadequate response to volume repletion and increased ventricular filling pressure, low cardiac output secondary to mechanical ventilation with positive end-expiratory pressure (peep). paediatric population: dobutamine is indicated in all paediatric age groups (from neonates to 18 years of age) as inotropic support in low cardiac output hypoperfusion states resulting from decompensated heart failure, following cardiac surgery, cardiomyopathies and in cardiogenic or septic shock. dobutamine stress echocardiography: dobutamine hydrochloride may be used as a substitute for physical exercise in stress testing in the diagnosis of coronary artery disease. precautions apply (refer to data sheet).